Poster Presentations
The Globalization of Pharmaceutics Education Network (GPEN) Executive Committee is pleased to showcase the outstanding poster abstracts received at the 12th biennial GPEN conference in Singapore. Please click the respective presentation code for a copy of the abstract.
Hide all events
orPoster presentations on Thu, 27th Sep
Code | Title | Author and affiliation |
---|---|---|
A1 | Development of iRGD conjugated semifluorinated nanoassemblies for targeted drug delivery to solid tumors Abstract | Montira TANGSANGASAKSRI, University of Wisconsin-Madison |
A2 | Developing chitosan nanoparticles loaded with scutellarin/ 2-hydroxypropyl-beta-cyclodextrin inclusion complexes for treatment of Alzheimer's Disease Abstract | Li ZHANG, National University of Singapore |
A3 | Photochemical internalization of targeted nanoparticles for the intracellular delivery of a cytotoxic protein. Abstract | Lucía Amine MARTÍNEZ JOTHAR, Utrecht University |
A4 | Formation and investigation of high-aspect ratio polymeric nanocapsules via vesicle templation with RAFT polymerization and their interactions with cells Abstract | Yunxin XIAO, Monash University |
A5 | Novel polymeric micelles for siRNA delivery Abstract | Franck MARQUET, University of Geneva |
A6 | Polymeric nanocarriers for intravitreal delivery | Vijayabhaskarreddy JUNNUTHULA, University of Helsinki |
A7 | Intraperitoneal delivery of neutron activatable mesoporous silica nanoparticles for the treatment of ovarian cancer peritoneal metastasis Abstract | Derek HARGROVE, University of Connecticut |
A8 | Development of exosome assembly formed by utilization of DNA hybridization and its application for cancer vaccine Abstract | Akihiro MATSUMOTO, Kyoto University |
A9 | Bioinspired cell-derived nanovesicles: a novel class of drug delivery systems Abstract | Yub Raj NEUPANE, National University of Singapore |
A10 | Phytantriol modified with DSPE-PEG2000: a temperature-responsive lipid-based nanomaterials for on-demand drug delivery Abstract | Xiaohan SUN, Monash University |
A11 | Particle design of porous PLGA microparticles encapsulating poor water-soluble drug as a novel inhalation formulation of lung cancer Abstract | Miho KOMATSU, Nagoya City University |
A12 | Modification of cationic solid lipid nanoparticles with hyaluronic acid to overcome multi drug resistance Abstract | Sang Eun LEE, Chungnam National University |
A13 | Quantification of nanoparticle uptake in human terminal hair follicle in the context of alopecia areata Abstract | Rebekka CHRISTMANN, University of Saarland |
A13b | Lipid-polymer hybrid nanoparticles (LPNs) for efficient pulmonary delivery of nucleic acids: Lessons learnt from quality-by-design based optimization Abstract | Kaushik THANKI, University of Copenhagen |
A14 | High density lipoprotein as a novel lymph-directing platform for immunotherapy delivery Abstract | Gracia GRACIA, Monash University |
A15 | Monocyte-targeted delivery to immune cells using Modified Polysaccharide particles Abstract | Franklin AFINJUOMO, University of South Australia |
A16 | Development of the first monoclonal antibody for detection of Elastin-like Polypeptides Abstract | Aida KOUHI, University of Southern California |
A17 | Enhanced oral absorption with nanostructured hydrogel biomaterials Abstract | Elizabeth LEVY, University of California San Francisco |
A18 | Nanofibrillated cellulose hydrogel as a lyoprotectant in the freeze-drying of HepG2 3D spheroids Abstract | Arto MERIVAARA, University of Helsinki |
A19 | Evaluation of taste-masking efficiency for the development of an orodispersible film formulation containing ondansetron hydrochloride Abstract | Wen Chin FOO, National University of Singapore |
A20 | Development of pH-responsive hydrated composite Eudragit-dendrimer formulations for drug delivery Abstract | Cheryl WONG, National University of Singapore |
A21 | Mesoporous silica nanoparticles (MSN) for antimicrobial peptide delivery: The Influence of PEG crosslinker length on activity Abstract | Vanitha SELVARAJAN, National University of Singapore |
A22 | Development of peptide-based oral vaccine against hookworm Abstract | Stacey BARTLETT, University of Queensland |
A23 | Drug delivery to the colon using polysaccharides degraded by the human microbiome and pH-responsive film coatings Abstract | Michael LANZ, University of Basel |
A24 | Development of microneedles coated with bleomycin for the treatment of skin warts Abstract | Han Sol LEE, Chungnam National University |
A25 | The use of light as a therapeutic agent for treatment of Diseases Abstract | Lili DUSE, University of Marburg |
A26 | Human adipose derived mesenchymal stromal cells cultured with wood derived nanofibrillar cellulose Abstract | Jasmi KIISKINEN, University of Helsinki |
A27 | A fast and precise method for the quantification of PLGA and gelatin based drug delivery systems Abstract | Aljoscha KÖNNEKE, University of Saarland |
A28 | New methods to evaluate the pharmaceutical equivalence of herbal drugs Abstract | Quyen TRAN THI, Chungnam National University |
A29 | Development, current applications and future roles of biorelevant two stage in vitro testing in drug development Abstract | Tom FIOLKA, Goethe University Frankfurt |
A30 | Effects of drug particle size and lipid additives on the degree of drug coating by paraffin wax in spray congealing Abstract | Hongyi OUYANG, National University of Singapore |
A31 | Influence of polymer structure on controlled release of docetaxel: a comparison of non-bio degradable polymer films for esophageal drug eluting stents Abstract | Fatemeh FOULADIAN, University of South Australia |
A32 | Design and physicochemical characterization of fenofibrate solid dispersion by supercritical anti-solvent process Abstract | JungBin AHN, Chungnam National University |
A33 | Effect of calcium ascorbate on the gastric acidity and bioavailability Abstract | Dong-Hyun KIM, Chungnam National University |
A34 | Homogeneous immunoassay for the detection of EGFR-HER2 heterodimerization on cell surface. Abstract | Sun Jin KIM, University of Utah |
A35 | Magnesium isoglycyrrhizinate inhibits SMAD2/3 pathway and induced senescence in TGF-?-activated hepatic stellate cells Abstract | Jie Kai TEE, National University of Singapore |
A36 | Nanomaterials as novel inhibitors that ameliorate fibrosis, adhesion and migration of hepatic stellate cells Abstract | Fei PENG, National University of Singapore |
A37 | Overexpression of PKCzeta-SUMO mutant in endothelial cells limits angiogenesis in breast cancer cell Abstract | Naehwan BAEK, Chungnam National University |
A38 | Palmitoylation of the apical sodium dependent bile acid transporter (ASBT;SLC10A2;IBAT) Abstract | Ebehiremen AYEWOH, University of Maryland |
A39 | Improvement of glucose homeostasis by cucurbitane triterpenoids from the fruits of Momordica charantia through IRS-1 activation in diabetic mice Abstract | Joo-Hui HAN, Chungnam National University |
A40 | Cytoprotective effects of hypothermia in various acute organ toxicities Abstract | Yeong Lan TAN, National University of Singapore |
A41 | Systems pharmacological analysis of a combination therapy to overcome HER2 and mTOR-therapies resistance in breast cancer Abstract | Tanaya VAIDYA, University of Florida |
A41b | Benznidazole combination therapy with new compound, Neq 821, has potential to protect mice against acute experimental infection of Chagas disease Abstract | Carla LOPES, University of São Paulo |
A42 | Synthesis of vaccine candidates against Group A Streptococcus Abstract | Chuankai DAI, University of Queensland |
A43 | Development of an aryloxazole class of Hepatitis C virus inhibitors targeting the entry stage of the viral replication cycle Abstract | Nicholas KLUS, University of North Carolina Chapel Hill |
A44 | Synthesis and biological evaluation of cationic amphiphilic indoles as antimycobacterial agents Abstract | Samuel Agyei NYANTAKYI, National University of Singapore |
A45 | Substitution of terminal amide with 1H-1,2,3-triazole: identification of unexpected class of potent antibacterial agents Abstract | Fangchao BI, Shandong University |
A46 | Design and evaluation of novel beta-hairpin peptides as anti-infectives Abstract | Nhan Dai Thien TRAM, National University of Singapore |
A47 | Complex speciation modeling to predict the effective concentrations of chelators in human plasma Abstract | John PRYBYLSKI, University of North Carolina Chapel Hill |
A48 | Development and in vitro Validation of a Computational Model to Predict MRP3 Inhibitors Abstract | Matthew WELCH, University of Maryland |
A49 | Multi-protein dynamic combinatorial chemistry: A novel strategy that leads to simultaneous discovery of subfamily-selective inhibitors against nucleic acid demethylases FTO and ALKBH3 Abstract | Mohua DAS, National University of Singapore |
A50 | Biomimetic fabrication of DOPA based nano-coatings for stimuli-responsive release system Abstract | Qinghua LYU, National University of Singapore |
A51 | Effects of mucilage extracts from Pereskia bleo leaves on blood coagulation Time Abstract | Kamonlawan CHOMCHOPBUN, National University of Singapore |
A53 | Pharmacokinetics study and biodistribution of HCPT-loaded tributyrin emulsion in rats Abstract | Shili YANG, National University of Singapore |
A54 | In vitro - in vivo correlation for two bioequivalent lidocaine patches under transient heat exposure Abstract | Sherin THOMAS, University of Maryland |
A55 | Development of mechanism based pharmacokinetics model for implementation of food effect on drug absorption Abstract | Hyun-moon BACK, Chungnam National University |
A56 | Prediction of human pharmacokinetics of subcutaneously administered depot formulation using MBPK model Abstract | Fiona Ge GAO, Goethe University Frankfurt |
A57 | Quantification of raloxifene in mouse plasma and tissues by ultra-high performance liquid chromatography-tandem mass spectrometry Abstract | Sumit BANSAL, National University of Singapore |
A58 | CNS delivery of VX-970: a selective ATR inhibitor for radiosensitization in GBM Abstract | Surabhi TALELE, University of Minnesota-Twin Cities |
A59 | Elucidation of transporters involved in tissue distribution and urinary excretion of proguanil and cycloguanil in mice Abstract | Yukana TOMODA, University of Tokyo |
A60 | Brain permeability of Apolipoprotein A1 (ApoA1): Implications for Alzheimer's Disease Abstract | Andrew ZHOU, University of Minnesota-Twin Cities |
A61 | Time-dependent inhibition of piperine and its impact on the metabolism of carbamazepine Abstract | Tianjing REN, The Chinese University of Hong Kong |
A62 | Melanosomal drug uptake in the retinal pigment epithelium Abstract | Laura HELLINEN, University of Eastern Finland |
A63 | Effect of permeability enhancers on paracellular transport of furosemide across Caco-2 cell monolayers Abstract | Nihan IZAT, Hacettepe University |
A64 | Development and optimization of a direct contact blood brain barrier model for in vitropermeability screening. Abstract | Kelsey LUBIN, Purdue University |
Poster presentations on Fri, 28th Sep
Code | Title | Author and affiliation |
---|---|---|
B1 | Novel mesoporous nanoparticles for the targeted delivery of anticancer agents to estrogen receptor overexpressing breast cancer Abstract | Candace DAY, University of South Australia |
B2 | Examining the interactions between mesoporous silica particles and digestion of dietary components Abstract | Kellie MAY, Monash University |
B3 | Calcium phosphate nanoparticles for the dual delivery of bisphosphonates and pDNA Abstract | Sofia BISSO, ETH Zurich |
B4 | Doxorubicin-loaded MPI conjugates: Synthesis and in-vitro characterization Abstract | Ankitkumar PARIKH, University of South Australia |
B5 | Chitosan nanoparticles for oral antigen delivery: a permeability approach. Abstract | Leah WRIGHT, University of South Australia |
B6 | Sublingual film of salmon calcitonin loaded hydroxyapatite nanoparticles as a non-invasive alternative to parenteral administration Abstract | Darsheen KOTAK, Institute of Chemical Technology |
B7 | Preparation of microRNA34a-loaded chitosan nanoparticles to upregulate the expression of microRNA-34a in MDA-MB-231 cells Abstract | Xiaoxia YANG, Shandong University |
B8 | Validation of purification methods for extracellular vesicles Abstract | Jacopo ZINI, University of Helsinki |
B9 | The microRNA regulatory landscape of MSC-derived exosomes: a systems view Abstract | Scott FERGUSON, University at Buffalo |
B10 | Development and in-vitro characterization of novel PLGA nanoparticles-Lipid Hybrid (PLH) microparticles for pulmonary delivery of rifampicin Abstract | Sajedehsadat MAGHREBI, University of South Australia |
B11 | Lymphatic uptake of liposomes after intraperitoneal administration primarily occurs via the diaphragmatic lymphatics and is surface property dependent Abstract | Given LEE, Monash University |
B12 | Self-nanoemulsifying Drug Delivery System of Resveratrol Trimethyl Ether: Preparation, Characterization and Pharmacokinetic Evaluation Abstract | Yu DAI, National University of Singapore |
B13 | Skin drug permeation characteristics of oligochitosan- and carboxymethyloligochitosan-carboxymethyl-5-fluorouracil conjugate nanoparticles Abstract | Mazita MOHD DIAZ, Universiti Teknologi Mara |
B14 | Enhanced photodynamic therapy using nanoencapsulated curcumin Abstract | Michael R. AGEL, University of Marburg |
B15 | Intratumoral injection of dextran-CpG oligonucleotide conjugates for enhanced immune-stimulation for cancer therapy Abstract | Hien NGUYEN, University of Otago |
B16 | Kinetic tuning of antibody-biogel interactions for enhanced barrier properties Abstract | Jennifer SCHILLER, University of North Carolina Chapel Hill |
B17 | PLGA implants for long-acting release of anti-VEGF monoclonal antibody in a rabbit retinal vascular leakage model Abstract | Jennifer WALKER, University of Michigan |
B18 | Indocyanine green loaded PLGA film coated coronary stents for photo-triggered in situ biofilm eradication Abstract | Hendrik VÖGELING, University of Marburg |
B19 | Impact of substrate stiffness on dermal papilla aggregates in hydrogel microgels Abstract | Justin TAN, National University of Singapore |
B20 | Electrospinning of high-content chitosan/polyethylene oxide fibers in GRAS acids Abstract | Mai BAY STIE, University of Copenhagen |
B21 | Using coiled coil forming peptide to attach a peptide with high affinity Abstract | Romain LEBOUX, Leiden University |
B22 | Infection responsive delivery of glycoside hydrolase and antibiotic combination Abstract | Chelsea THORN, University of South Australia |
B23 | Development of the stable long acting injectable parenteral dosage form of Omeprazole for horses Abstract | Yunmei SONG, University of South Australia |
B24 | In vivo brain delivery of proteins through the BBB Abstract | Brian KOPEC, University of Kansas |
B25 | Mitigation of the pharmaceutical food effect: Investigation of nanocrystals and lipids Abstract | Tahlia MEOLA, University of South Australia |
B26 | A high-throughput method to predict the in vivo exposure of different drug delivery systems Abstract | Caroline ALVEBRATT, Uppsala University |
B27 | Evaluation of effect of minor manufacturing changes and establishment of IVIVC for compositionally equivalent parenteral microsphere drug products Abstract | Janki ANDHARIYA, University of Connecticut |
B28 | Design of solubility studies in the context of BCS biowaiver monographs Abstract | Gerlinde PLÖGER, Goethe University Frankfurt |
B29 | Effect of proteins radicals on the stability of polysorbate 80: fatty acid cis-trans isomerization Abstract | Indira PRAJAPATI, University of Kansas |
B30 | Correlating the effect of magnesium stearate hydrate form, chemical composition and particle size with tablet dissolution Abstract | Julie CALAHAN, University of Kentucky |
B31 | Effect of polymeric matrix and film formulation on development of verapamil extended release tablet Abstract | Arnas LAKHIEW, Chulalongkorn University |
B32 | The comparison between co-melted and spray dried clotrimazole-PVP/VA solid dispersions systems Abstract | Ahmad Ghazali ISMAIL, Universiti Sains Malaysia |
B33 | Formulation development of a recombinant protein based non-replicating rotavirus (NRRV) vaccine candidate: Antigen-adjuvant-preservative interactions Abstract | Sanjeev AGARWAL, University of Kansas |
B34 | Structurally defined heparan sulfate protects from acetaminophen-induced acute liver failure Abstract | Katelyn ARNOLD, University of North Carolina Chapel Hill |
B35 | Clioquinol-mediated distribution of zinc and copper regulates the blood-brain barrier expression of breast cancer resistance protein (ABCG2) Abstract | Chris YAP, Monash University |
B36 | Doxorubicin prodrug that binds apoptotic cells and activated by apoptotic caspase-3 as a component of concurrent chemoradiotherapy for improved therapeutic index Abstract | Youngseok CHO, Seoul National University |
B37 | Radio-gene therapy targeting RanBP17 gene for down regulation of tumour proliferation in head and neck carcinomas Abstract | Shashank Reddy PINNAPIREDDY, University of Marburg |
B38 | Effect of autophagy regulation on apoptosis in platelet-derived growth factor-BB stimulated vascular smooth muscle cells Abstract | Do-Hyung LEE, Chungnam National University |
B39 | Antigen-drug conjugates in the treatment of autoimmunity Abstract | Matthew CHRISTOPHER, University of Kansas |
B40 | A study of functional analyses for carboxylesterase type 2 isozymes of cynomolgus monkeys Abstract | Maori TANAKA, Kumamoto University |
B41 | Disease interception of autoimmune disease using soluble antigen arrays Abstract | Melissa PRESSNALL, University of Kansas |
B41b | Perception, attitudes and knowledge of pharmacists towards antimicrobial stewardship at nursing homes Abstract | Aysu SELCUK, National University of Singapore |
B42 | The structure-stability-toxicity relationships of L-DOPA and dopamine thioethers in neuronal cultures Abstract | Sanzhar KARATAYEV, National University of Singapore |
B43 | Design and comparative evaluation of the anticonvulsant profile, carbonic- anhydrate inhibition and teratogenicity of novel carbamate derivatives of branched aliphatic carboxylic Acids with 4-aminobenzensulfonamide Abstract | David BIBI, The Hebrew University of Jerusalem |
B44 | Targeted delivery of potent immunosuppressants for treatment of ulcerative colitis Abstract | Peter KLEINDL, University of Kansas |
B45 | Synthesis and mycobacterial dihydrofolate reductase inhibitory activity evaluation of 4,6-diamino-1,2-dihydro-2-aryl-1-alkyoxyphenyl[1,3,5]triazines Abstract | Edward LONG, Naitonal University of Singapore |
B46 | Advances in the development of peptidomimetics as potential antimicrobials: A Comparison of Tetrameric and Octameric Peptoids Abstract | Bettina FLECK, National University of Singapore |
B47 | Calcaratarin D attenuates inflammatory responses through the inhibition of NF-kB activation Abstract | Thi Ngoc Quy TRAN, National University of Singapore |
B48 | Development of a aacromolecular prodrug of tofacitinib for the sustained treatment of inflammatory arthritis Abstract | Xin WEI, University of Nebraska Medical Center |
B49 | Polymorphs of an orally available analogue of diethylenetriaminepentaacetic acid: physical and thermal characterization Abstract | Carla COSTE SANCHEZ, University of North Carolina Chapel Hill |
B50 | Medicinal plants used for erectile dysfunction Abstract | Valerie SIN, National University of Singapore |
B51 | Reversible single crystal-to-single crystal phase transition with low-temperature induced twinning of diphenhydramine citrate Salt Abstract | Kunlin WANG, University of Minnesota-Twin Cities |
B53 | Inhibition of human aldehyde oxidase by bazedoxifene and lasofoxifene Abstract | Shiyan CHEN, National University of Singapore |
B54 | Slow and tight binding inhibition kinetics of CYP17A1 by abiraterone and its active metabolite Abstract | Eleanor CHEONG, National University of Singapore |
B55 | Human CYP2J2 inhibition by azole antifungals Abstract | Jacqueline LEOW, National University of Singapore |
B56 | In vitro quantification of sequential metabolism kinetics of â9-tetrahydrocannabinol and its metabolites Abstract | Gabriela PATILEA-VRANA, University of Washington |
B57 | Investigation of the discriminatory power of dissolution specifications for a BCS-based biowaiver via pharmacokinetic modeling Abstract | Martin HOFSÄSS, Goethe University Frankfurt |
B58 | A pharmacometabolomics approach for predicting tenofovir diphosphate (TFV-DP) concentrations in dried blood spots (DBS) Abstract | Mustafa IBRAHIM, University of Colorado |
B59 | Pharmacokinetic and allometric ccaling studies of nanoparticle formulations of anthracyclines Abstract | James BEAUDOIN, University of North Carolina Chapel Hill |
B60 | Tryptophan metabolism and IDO/TDO expression in bladder cancer: A case-control study in Singapore Abstract | Sze-Han LEE, National University of Singapore |
B61 | Pharmacokinetic disposition of cox-inhibitors for the prevention/treatment of colorectal cancer Abstract | Glenn LEMMENS, KU Leuven |
B62 | A microfluidic enzymatic digestive system based on chaotic micromixers Abstract | Pim DE HAAN, University of Groningen |
B63 | Predicting pulmonary pharmacokinetics from in vitro properties of dry powder inhalers Abstract | Mong-Jen CHEN, University of Florida |
B64 | Primary human hepatocyte spheroids cultured and used in high-throughput screening format Abstract | Niklas HANDIN, Uppsala University |